HIT Policy Committee Advisory Meeting; Notice of Meeting, 57567 [2012-22988]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 181 / Tuesday, September 18, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
HIT Policy Committee Advisory
Meeting; Notice of Meeting
Office of the National
Coordinator for Health Information
Technology, HHS.
ACTION: Notice of meeting.
AGENCY:
mstockstill on DSK4VPTVN1PROD with NOTICES
This notice announces a forthcoming
meeting of a public advisory committee
of the Office of the National Coordinator
for Health Information Technology
(ONC). The meeting will be open to the
public.
Name of Committee: HIT Policy
Committee.
General Function of the Committee: To
provide recommendations to the National
Coordinator on a policy framework for the
development and adoption of a nationwide
health information technology infrastructure
that permits the electronic exchange and use
of health information as is consistent with
the Federal Health IT Strategic Plan and that
includes recommendations on the areas in
which standards, implementation
specifications, and certification criteria are
needed.
Date and Time: The meeting will be held
on October 3, 2012, from 10 a.m. to 3 p.m./
Eastern Time.
Location: The Dupont Circle Hotel, 1500
New Hampshire Avenue NW., Washington
DC 20036. For up-to-date information, go to
the ONC Web site, https://healthit.hhs.gov
Contact Person: MacKenzie Robertson,
Office of the National Coordinator, HHS, 355
E Street SW., Washington, DC 20201, 202–
205–8089, Fax: 202–260–1276, email:
mackenzie.robertson@hhs.gov. Please call the
contact person for up-to-date information on
this meeting. A notice in the Federal Register
about last minute modifications that impact
a previously announced advisory committee
meeting cannot always be published quickly
enough to provide timely notice.
Agenda: The committee will hear reports
from its workgroups and updates from ONC
and other Federal agencies. ONC intends to
make background material available to the
public no later than two (2) business days
prior to the meeting. If ONC is unable to post
the background material on its Web site prior
to the meeting, it will be made publicly
available at the location of the advisory
committee meeting, and the background
material will be posted on ONC’s Web site
after the meeting, at https://healthit.hhs.gov
Procedure: ONC is committed to the
orderly conduct of its advisory committee
meetings. Interested persons may present
data, information, or views, orally or in
writing, on issues pending before the
Committee. Written submissions may be
made to the contact person on or before two
days prior to the Committee’s meeting date.
Oral comments from the public will be
scheduled in the agenda. Time allotted for
each presentation will be limited to three
minutes. If the number of speakers requesting
to comment is greater than can be reasonably
accommodated during the scheduled public
VerDate Mar<15>2010
18:39 Sep 17, 2012
Jkt 226001
comment period, ONC will take written
comments after the meeting until close of
business on that day.
Persons attending ONC’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
ONC welcomes the attendance of the
public at its advisory committee meetings.
Seating is limited at the location, and ONC
will make every effort to accommodate
persons with physical disabilities or special
needs. If you require special accommodations
due to a disability, please contact MacKenzie
Robertson at least seven (7) days in advance
of the meeting.
Notice of this meeting is given under the
Federal Advisory Committee Act (Pub. L. 92–
463, 5 U.S.C., App. 2).
Dated: September 11, 2012.
MacKenzie Robertson,
FACA Program Lead, Office of Policy and
Planning, Office of the National Coordinator
for Health Information Technology.
[FR Doc. 2012–22988 Filed 9–17–12; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Single Source Cooperative Agreement
Award for World Health Organization
Department of Health and
Human Services (HHS), Assistant
Secretary for Preparedness and
Response (ASPR).
ACTION: Notification of Single Source
Cooperative Agreement Award for
World Health Organization for a grant
titled: ‘‘Smallpox Research Oversight
Activities: WHO Advisory Committee
on Variola Virus Research’’.
AGENCY:
Statutory Authority: Sections 301 and
319L of the Public Health Service Act,
(42 U.S.C. 241 and 247d–7e).
Estimated Amount of Award:
$400,000.
Project Period: Sept. 30, 2012 to Sept.
29, 2013.
SUMMARY: A natural re-emergence of
smallpox is not deemed possible, but if
it were to occur as a result of a terrorist
or deliberate event, it would be a
potentially devastating threat to public
health worldwide and would constitute
a public health emergency of
international concern (PHEIC) under the
International Health Regulations (IHR)
(2005). A case of smallpox detected by
a member state requires notification to
World Health Organization (WHO) as
soon as possible, and any confirmed
smallpox case would generate an
immediate global public health
response.
WHO must rely on fast and reliable
laboratory diagnostic capacity
worldwide to be able to identify a re-
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
57567
emergence of smallpox, particularly in
countries where systemic orthopoxvirus
infections such as monkeypox, vaccinia
virus infection or cowpox, and other
non-pox viral rash illnesses, such as
chicken pox, may cause clinical
diagnostic confusion.
Over the past 10 years, clinical
virology laboratory diagnostics has been
evolving and increasingly rely on
molecular techniques. This is also true
with laboratory diagnoses of poxvirus
infections. Precise and consistent
identification of orthopoxviruses, in
particular variola viruses, is now
achievable using such molecular
techniques as real-time Polymerase
Chain Reaction (unlike earlier
techniques that may have relied on
direct virus isolation and identification).
WHO must be alerted when there is
a potential or actual smallpox infection.
Early detection and confirmation of
smallpox cannot rely solely on the two
WHO Collaborating Centres for
smallpox and other poxvirus infections.
In order to facilitate and support a
prompt and effective response to
mitigate the spread of the disease, these
two Centres should be supported by a
worldwide network of reliable
laboratories able to perform PCR and
real-time PCR diagnostics enabling
initial detection and identification of
smallpox events.
Additionally, the U.S. Government
supports the development of other
medical products, including vaccines
and drugs, for use within the U.S. upon
verification of a smallpox case. The U.S.
government, through the Office of the
Assistant Secretary for Preparedness
and Response (ASPR), has successfully
developed vaccine products, and is
actively engaged in the development of
several drug candidates for smallpox
therapies, which require access to the
Variola virus to satisfy regulatory
requirements for product approvals.
Single Source Justification
WHO is the only eligible applicant; it
is the only organization that is allowed
by international agreements to address
the issues outlined in this proposal.
WHO is the directing and coordinating
authority for health within the United
Nations system. It is responsible for
providing leadership on global health
matters, shaping the health research
agenda, setting norms and standards,
articulating evidence-based policy
options, providing technical support to
countries, and monitoring and assessing
health trends. In the 21st century, health
is a shared responsibility, involving
equitable access to essential care and
collective defense against transnational
threats. States Parties to the U.N. have
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 77, Number 181 (Tuesday, September 18, 2012)]
[Notices]
[Page 57567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22988]
[[Page 57567]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
HIT Policy Committee Advisory Meeting; Notice of Meeting
AGENCY: Office of the National Coordinator for Health Information
Technology, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Office of the National Coordinator for Health
Information Technology (ONC). The meeting will be open to the public.
Name of Committee: HIT Policy Committee.
General Function of the Committee: To provide recommendations to
the National Coordinator on a policy framework for the development
and adoption of a nationwide health information technology
infrastructure that permits the electronic exchange and use of
health information as is consistent with the Federal Health IT
Strategic Plan and that includes recommendations on the areas in
which standards, implementation specifications, and certification
criteria are needed.
Date and Time: The meeting will be held on October 3, 2012, from
10 a.m. to 3 p.m./Eastern Time.
Location: The Dupont Circle Hotel, 1500 New Hampshire Avenue
NW., Washington DC 20036. For up-to-date information, go to the ONC
Web site, https://healthit.hhs.gov
Contact Person: MacKenzie Robertson, Office of the National
Coordinator, HHS, 355 E Street SW., Washington, DC 20201, 202-205-
8089, Fax: 202-260-1276, email: mackenzie.robertson@hhs.gov. Please
call the contact person for up-to-date information on this meeting.
A notice in the Federal Register about last minute modifications
that impact a previously announced advisory committee meeting cannot
always be published quickly enough to provide timely notice.
Agenda: The committee will hear reports from its workgroups and
updates from ONC and other Federal agencies. ONC intends to make
background material available to the public no later than two (2)
business days prior to the meeting. If ONC is unable to post the
background material on its Web site prior to the meeting, it will be
made publicly available at the location of the advisory committee
meeting, and the background material will be posted on ONC's Web
site after the meeting, at https://healthit.hhs.gov
Procedure: ONC is committed to the orderly conduct of its
advisory committee meetings. Interested persons may present data,
information, or views, orally or in writing, on issues pending
before the Committee. Written submissions may be made to the contact
person on or before two days prior to the Committee's meeting date.
Oral comments from the public will be scheduled in the agenda. Time
allotted for each presentation will be limited to three minutes. If
the number of speakers requesting to comment is greater than can be
reasonably accommodated during the scheduled public comment period,
ONC will take written comments after the meeting until close of
business on that day.
Persons attending ONC's advisory committee meetings are advised
that the agency is not responsible for providing access to
electrical outlets.
ONC welcomes the attendance of the public at its advisory
committee meetings. Seating is limited at the location, and ONC will
make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a
disability, please contact MacKenzie Robertson at least seven (7)
days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (Pub. L. 92-463, 5 U.S.C., App. 2).
Dated: September 11, 2012.
MacKenzie Robertson,
FACA Program Lead, Office of Policy and Planning, Office of the
National Coordinator for Health Information Technology.
[FR Doc. 2012-22988 Filed 9-17-12; 8:45 am]
BILLING CODE 4150-45-P
